Angiotensin converting enzyme inhibitors should be avoided in AKI and are also not recommended infants <44 weeks post menstrual age due to potential risk of precipitous and profound drop in blood pressure, hyperkalaemia, or AKI (137, 142, 143). The gene discussed is ACE; the disease is acute kidney injury.